RXRA and B-cell chronic lymphocytic leukemia: Although future work is required to fully elucidate the role of RA in the CLL microenvironment, our findings reveal that mouse and human leukemic cells could be distinguished from normal B-cells by their increased expression of Rarγ2 and RXRα respectively, thus indicating they are equipped with the machinery to activate RA-target genes upon RA-binding.